Meisheri K D, Palmer R F, Van Breemen C
Eur J Pharmacol. 1980 Jan 25;61(2):159-65. doi: 10.1016/0014-2999(80)90158-2.
Amrinone, a known positive inotropic agent in the heart, was found to cause a dose-dependent (10--100 micrograms/ml) inhibition of norepinephrine (NE) or high-K+-induced contractions of rabbit aorta. Amrinone also inhibited carbachol or high-K+-induced contractions of guinea-pig taenia coli. Neither total tissue 45Ca uptake nor the rate of 45Ca uptake induced by 80 mM K+ in rabbit aorta was altered by pretreatment with amrinone. On the other hand, a similar pretreatment with amrinone inhibited NE (10(-6) or 10(-5) M) induced tissue 45Ca uptake. Amrinone (100 micrograms/ml) caused about a 70% increase in cAMP concentration over resting levels. It is concluded that amrinone causes a nonspecific inhibition of smooth muscle contractility by acting probably at multiple sites to decrease the availability of Ca2+ required for activation. One or more of these mechanisms may involve cAMP.
氨力农是一种已知的心脏正性肌力药物,它能引起兔主动脉对去甲肾上腺素(NE)或高钾诱导的收缩产生剂量依赖性(10 - 100微克/毫升)抑制。氨力农还能抑制豚鼠结肠带对卡巴胆碱或高钾诱导的收缩。氨力农预处理并未改变兔主动脉中总组织45Ca摄取量或80 mM钾诱导的45Ca摄取速率。另一方面,类似的氨力农预处理抑制了NE(10(-6)或10(-5) M)诱导的组织45Ca摄取。氨力农(100微克/毫升)使环磷酸腺苷(cAMP)浓度比静息水平升高约70%。结论是,氨力农可能通过作用于多个部位来降低激活所需的Ca2+可用性,从而对平滑肌收缩性产生非特异性抑制。这些机制中的一种或多种可能涉及cAMP。